Patent · US Active

Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy

US8853196B2 · kind B2 · utility

1Cited by

21References

14Claims

0Family size

Assignee

Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

Wilhelm Amberg · Ludwigshafen, DE
Udo Lange · Ludwigshafen, DE
Frauke Pohlki · Wiesbaden, DE

Key dates

Filing date	Aug 3, 2012
Grant date	Oct 7, 2014
Priority date	—
Expiry date	Aug 3, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I)or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.